Results 341 to 350 of about 160,364 (357)

Serum GFAP as a biomarker for disease severity in multiple sclerosis

Scientific Reports, 2018
Ahmed Abdelhak, Jan Kassubek, Hayrettin Tumani   +2 more
exaly  

Plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross‐sectional and longitudinal study in the AIBL cohort

Alzheimer's and Dementia, 2023
exaly  

Autoimmune GFAP astrocytopathy: Prospective evaluation of 90 patients in 1 year

Journal of Neuroimmunology, 2018
, Anastasia Zekeridou, Eoin Flanagan
exaly  

Beneficial effects of gfap/vimentin reactive astrocytes for axonal remodeling and motor behavioral recovery in mice after stroke

Glia, 2014
Zhongwu Liu, Mei Lu, Ulrika Wilhelmsson
exaly  

GFAP-immunopositive astrocytes in schizophrenia

Schizophrenia Research, 2004
Serge Weis, Ida C. Llenos
openaire   +1 more source

Density of GFAP-immunoreactive astrocytes is decreased in left hippocampi in major depressive disorder

Neuroscience, 2016
Gouri Mahajan
exaly  

Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients

Journal of Neurology, Neurosurgery and Psychiatry, 2018
Raffaele Iorio, Valentina Damato, Amelia Evoli   +2 more
exaly  

S100B expression defines a state in which GFAP‐expressing cells lose their neural stem cell potential and acquire a more mature developmental stage

Glia, 2007
Christian Delphin, Jacques Baudier
exaly  

GFAP Isoforms in Adult Mouse Brain with a Focus on Neurogenic Astrocytes and Reactive Astrogliosis in Mouse Models of Alzheimer Disease

PLoS ONE, 2012
Elly M Hol
exaly  

EIF2B5 mutations compromise GFAP+ astrocyte generation in vanishing white matter leukodystrophy

Nature Medicine, 2005
exaly